OPERF
JNCE

Oregon Public Employees Retirement Fund’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25,166
Closed -$176K – 1604
2020
Q4 		$176K Buy
+25,166
New +$196K ﹤0.01% 1515

Other funds holding JNCE

TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Oregon Public Employees Retirement Fund's JNCE Position: Q1 2021 in Review

Oregon Public Employees Retirement Fund sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q1 2021, closing a stake of 25,166 shares — an estimated $176K sold.

Oregon Public Employees Retirement Fund first reported a position in JNCE in Q4 2020 and held it in 1 quarter. The position peaked at $176K in Q4 2020. 124 funds tracked by Wall St. Rank hold JNCE as of Q1 2021.

  • Oregon Public Employees Retirement Fund reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Oregon Public Employees Retirement Fund sold 25,166 Jounce Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $176K.
  • Oregon Public Employees Retirement Fund first reported a position in Jounce Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Oregon Public Employees Retirement Fund's Jounce Therapeutics, Inc. Common Stock position peaked at $176K in Q4 2020.
  • 124 funds tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q1 2021, filed 20 Apr 2021.